295 related articles for article (PubMed ID: 22952919)
1. Distinct and competitive regulatory patterns of tumor suppressor genes and oncogenes in ovarian cancer.
Zhao M; Sun J; Zhao Z
PLoS One; 2012; 7(8):e44175. PubMed ID: 22952919
[TBL] [Abstract][Full Text] [Related]
2. Oncogenes and tumor suppressor genes: comparative genomics and network perspectives.
Zhu K; Liu Q; Zhou Y; Tao C; Zhao Z; Sun J; Xu H
BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S8. PubMed ID: 26099335
[TBL] [Abstract][Full Text] [Related]
3. Identification of consistent post-translational regulatory triplets related to oncogenic and tumour suppressive modulators in childhood acute lymphoblastic leukemia.
Wee Y; Liu Y; Zhao M
PeerJ; 2021; 9():e11803. PubMed ID: 34316412
[TBL] [Abstract][Full Text] [Related]
4. Synergetic regulatory networks mediated by oncogene-driven microRNAs and transcription factors in serous ovarian cancer.
Zhao M; Sun J; Zhao Z
Mol Biosyst; 2013 Dec; 9(12):3187-98. PubMed ID: 24129674
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor genes associated with drug resistance in ovarian cancer (review).
Yin F; Liu X; Li D; Wang Q; Zhang W; Li L
Oncol Rep; 2013 Jul; 30(1):3-10. PubMed ID: 23660957
[TBL] [Abstract][Full Text] [Related]
6. A novel framework for inferring condition-specific TF and miRNA co-regulation of protein-protein interactions.
Zhang J; Le TD; Liu L; He J; Li J
Gene; 2016 Feb; 577(1):55-64. PubMed ID: 26611531
[TBL] [Abstract][Full Text] [Related]
7. Investigation of hypoxia networks in ovarian cancer via bioinformatics analysis.
Zhang K; Kong X; Feng G; Xiang W; Chen L; Yang F; Cao C; Ding Y; Chen H; Chu M; Wang P; Zhang B
J Ovarian Res; 2018 Feb; 11(1):16. PubMed ID: 29482638
[TBL] [Abstract][Full Text] [Related]
8. New Insight into microRNA Functions in Cancer: Oncogene-microRNA-Tumor Suppressor Gene Network.
Zhou K; Liu M; Cao Y
Front Mol Biosci; 2017; 4():46. PubMed ID: 28736730
[TBL] [Abstract][Full Text] [Related]
9. Concordance of copy number loss and down-regulation of tumor suppressor genes: a pan-cancer study.
Zhao M; Zhao Z
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):532. PubMed ID: 27556634
[TBL] [Abstract][Full Text] [Related]
10. The OncoPPi network of cancer-focused protein-protein interactions to inform biological insights and therapeutic strategies.
Li Z; Ivanov AA; Su R; Gonzalez-Pecchi V; Qi Q; Liu S; Webber P; McMillan E; Rusnak L; Pham C; Chen X; Mo X; Revennaugh B; Zhou W; Marcus A; Harati S; Chen X; Johns MA; White MA; Moreno C; Cooper LA; Du Y; Khuri FR; Fu H
Nat Commun; 2017 Feb; 8():14356. PubMed ID: 28205554
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics methods for identifying differentially expressed genes and signaling pathways in nano-silica stimulated macrophages.
Zhang L; Hao C; Li J; Qu Y; Bao L; Li Y; Yue Z; Zhang M; Yu X; Chen H; Zhang J; Wang D; Yao W
Tumour Biol; 2017 Jun; 39(6):1010428317709284. PubMed ID: 28653889
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatic analysis reveals MIR502 as a potential tumour suppressor in ovarian cancer.
Li Y; Wang Q; Ning N; Tang F; Wang Y
J Ovarian Res; 2020 Jul; 13(1):77. PubMed ID: 32660514
[TBL] [Abstract][Full Text] [Related]
13. IL-22 Impedes the Proliferation of Schwann cells: Transcriptome Sequencing and Bioinformatics Analysis.
Xu S; Ao J; Gu H; Wang X; Xie C; Meng D; Wang L; Liu M
Mol Neurobiol; 2017 May; 54(4):2395-2405. PubMed ID: 26960328
[TBL] [Abstract][Full Text] [Related]
14. The co-regulatory networks of tumor suppressor genes, oncogenes, and miRNAs in colorectal cancer.
Slattery ML; Herrick JS; Mullany LE; Samowitz WS; Sevens JR; Sakoda L; Wolff RK
Genes Chromosomes Cancer; 2017 Nov; 56(11):769-787. PubMed ID: 28675510
[TBL] [Abstract][Full Text] [Related]
15. DORGE: Discovery of Oncogenes and tumoR suppressor genes using Genetic and Epigenetic features.
Lyu J; Li JJ; Su J; Peng F; Chen YE; Ge X; Li W
Sci Adv; 2020 Nov; 6(46):. PubMed ID: 33177077
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of genes, pathways, and TFs in nonsmoking Taiwan females with lung cancer.
Lv M; Wang L
Exp Lung Res; 2015 Mar; 41(2):74-83. PubMed ID: 25514196
[TBL] [Abstract][Full Text] [Related]
17. Screening candidate genes associated with bladder cancer using DNA microarray.
Xu A; Wang C; Sun S
Mol Med Rep; 2014 Dec; 10(6):3087-91. PubMed ID: 25323786
[TBL] [Abstract][Full Text] [Related]
18. Network analysis of microRNAs and their regulation in human ovarian cancer.
Schmeier S; Schaefer U; Essack M; Bajic VB
BMC Syst Biol; 2011 Nov; 5():183. PubMed ID: 22050994
[TBL] [Abstract][Full Text] [Related]
19. Oncogenes without a Neighboring Tumor-Suppressor Gene Are More Prone to Amplification.
Wu WK; Li X; Wang X; Dai RZ; Cheng AS; Wang MH; Kwong T; Chow TC; Yu J; Chan MT; Wong SH
Mol Biol Evol; 2017 Apr; 34(4):903-907. PubMed ID: 28087780
[TBL] [Abstract][Full Text] [Related]
20. Systems biology approach identifies key regulators and the interplay between miRNAs and transcription factors for pathological cardiac hypertrophy.
Recamonde-Mendoza M; Werhli AV; Biolo A
Gene; 2019 May; 698():157-169. PubMed ID: 30844478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
